Metabolomics analysis of the antidepressant prescription Danzhi Xiaoyao Powder in a rat model of Chronic Unpredictable Mild Stress (CUMS)

• Published in: Journal of ethnopharmacology Vol. 260; p. 112832
• Main Authors: Zhu, Yong-liang, Li, Shuang-long, Zhu, Chun-yang, Wang, Wan, Zuo, Wen-fei, Qiu, Xiang-jun
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 05.10.2020
• Subjects: Animals; Antidepressive Agents - pharmacology; Behavior, Animal - drug effects; Biomarkers - blood; Chromatography, High Pressure Liquid; CUMS; Danzhi Xiaoyao powder; Depression; Depression - blood; Depression - drug therapy; Depression - psychology; Disease Models, Animal; Drugs, Chinese Herbal - pharmacology; Energy Metabolism - drug effects; Exploratory Behavior - drug effects; Food Preferences - drug effects; Male; Metabolomics; Motor Activity - drug effects; Powders; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Stress, Psychological - blood; Stress, Psychological - drug therapy; Stress, Psychological - psychology; Tandem Mass Spectrometry; UPLC/Q-TOF-MS; Danzhi Xiaoyao powder; Metabolomics; Depression; UPLC/Q-TOF-MS; CUMS
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2020.112832

Danzhi Xiaoyao Powder (DZXY) is a classical prescription, that has been extensively used in traditional Chinese medicine (TMC) to treat depression for many years. However, the mechanism of DZXY is still unclear. The aim was to investigate the mechanism of the antidepressant effect of DZXY on a rat model of chronic unpredictable mild stress (CUMS). Forty male SD (Sprague-Dawley) rats with similar open field test (OFT) results were randomLy divided into a control group (n = 10) and an experimental group (n = 30). A depression model was established in the experimental group using the CUMS method. After the CUMS model was established successfully, the rats were randomLy divided into a depression model group and a DZXY group. The DZXY group was fed DZXY, while the depression model group and control group were given an equal amount of 0.5% sodium carboxymethyl cellulose suspension. Intragastric administration was performed once daily for 14 consecutive days. Animal weight, the sugar preference test, the open field test and the forced swimming test were used to evaluate the modeling effect and the antidepressant effect of DZXY. After the experiment, the plasma of rats was collected and the changes in plasma metabolites were analyzed by UPLC/Q-TOF-MS. The UPLC/Q-TOF-MS spectra data were evaluated by pattern recognition analysis to determine the changes in endogenous metabolites in the rat plasma samples. The results of the behavioral investigation showed that the rat model of depression was successfully replicated and that DZXY had an antidepressant effect. Using the UPLC-MS/MS metabolomics platform, partial least squares (PLS) and orthogonal partial least squares (OPLS), metabolic profile models (R2 and Q2 ≥ 0.5) of rat plasma were successfully constructed. The model could distinguish among the control group, the depression model group and the DZXY group. Finally, 38 differential metabolites were identified in the plasma. According to KEGG (http://www.kegg.jp) pathway analysis, amino acid metabolism, lipid metabolism, purine metabolism, the prolactin signaling pathway and bile secretion were enriched and represented the main metabolic pathways influenced in the plasma. This study successfully established a CUMS depression model. A total of 38 differential metabolites associated with depression were identified in the plasma of rats, 24 of which were modulated by DZXY. These results suggest that DZXY can improve excitability and play an antidepressant role by regulating phenylalanine metabolism, arachidonic acid metabolism, porphyrin metabolism, D-arginine and D-ornithine metabolism, steroid hormone biosynthesis, unsaturated fatty acid biosynthesis and steroid biosynthesis. [Display omitted]